Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial Journal Article

   

Authors:	Sumiyoshi, T.; Wang, X.; Warner, E. W.; Sboner, A.; Annala, M.; Sigouros, M.; Beja, K.; Mizuno, K.; Ku, S.; Fazli, L.; Eastham, J.; Taplin, M. E.; Simko, J.; Halabi, S.; Morris, M. J.; Gleave, M. E.; Wyatt, A. W.; Beltran, H.
Article Title:	Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial
Journal Title:	JNCI: Journal of the National Cancer Institute
Volume:	116
Issue:	1
ISSN:	0027-8874
Publisher:	Oxford University Press
Date Published:	2024-01-01
Start Page:	115
End Page:	126
Language:	English
DOI:	10.1093/jnci/djad184
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
PMCID:	PMC10777679
PUBMED:	37676819
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=174784029&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/213624